2025 年 04 月 21 日 关注优质底仓大盘以及临期转债 ▌市场展望与策略推荐 美国目前的情况与互联网泡沫破裂时（2001 年）非常相似， 川普政府一系列逆全球化操作，也正是上述经济背景下看似 偶然、实则必然的结果。从不好的一面来看，中国实际经济 增速将受到一定程度的冲击，具体影响尚有待观察；从好的 一面来看，美国主打的科技的估值或将被重新进行系统性的 重估，而中国也迎来了历史性的机遇，如果我们不忘初心、 文化自信，西降东升或已开启，重点关注人民币汇率是否开 始逐步进入升值通道。债市方面，一年期国债收益率基本接 券 研 究 报 告 固 定 收 益 研 分析师：罗云峰 S1050524060001 luoyf2@cfsc.com.cn 分析师：杨斐然 S1050524070001 yangfr@cfsc.com.cn 相关研究 1、《价值权益资产仍最具性价比— —资产配置周报》2025-04-20 2、《转债表现出较强估值保护》 2025-04-13 3、《看多价值——资产配置周报》 2025-04-13 投资要点 ▌ 股债、转债市场回顾 上周权益市场仍受关税政策反复影响，防御情绪偏强，整体 缩量震荡，银 ...

Market Performance - The Shanghai Composite Index increased by 1.19% this week, while the ChiNext Index decreased by 0.64%. The CSI 300 rose by 0.59%, and the CITIC Basic Chemical Index and Shenwan Chemical Index increased by 0.25% and 0.31%, respectively [1]. Chemical Subsector Performance - The top five performing subsectors in the chemical industry this week were dyeing chemicals (5.17%), nylon (4.77%), polyester (4.61%), phosphate and phosphorus chemicals (3.34%), and rubber additives (2.42%). The bottom five were other chemical raw materials (-2.94%), tires (-2.02%), rubber products (-1.43%), viscose (-1.3%), and soda ash (-0.89%) [1]. Industry Developments - Chuanjinnuo plans to invest 1.934 billion yuan in a phosphate chemical project in Egypt, which includes the construction of various facilities with a total annual production capacity of 800,000 tons of sulfuric acid and other phosphate products. The project aims to optimize cost structure by reducing raw material import costs [2]. - Zhejiang Jianglan signed a contract to build a 300,000-ton bio-jet fuel project in Zhoushan, with a total investment of 1.5 billion yuan. The project is expected to generate an annual output value of over 3.6 billion yuan upon reaching full capacity [2]. Investment Themes - Investment Theme 1: Domestic tire companies have strong competitiveness, with scarce growth targets worth attention. Suggested companies include Sailun Tire, Senqilin, General Motors, and Linglong Tire [2]. - Investment Theme 2: The consumer electronics sector is expected to gradually recover, benefiting upstream material companies. Suggested companies include Dongcai Technology, Stik, Light Technology, and Ruile New Materials [3]. - Investment Theme 3: Focus on resilient cyclical industries and inventory destocking leading to a bottom reversal. Suggested companies include Yuntianhua, Chuanheng Co., Xingfa Group, and Batian Co. in the phosphate chemical sector, and Juhua Co., Sanmei Co., and Yonghe Co. in the fluorochemical sector [4]. - Investment Theme 4: With economic recovery and demand resurgence, leading companies in the chemical sector are expected to benefit significantly. Suggested companies include Wanhua Chemical, Hualu Hengsheng, and Baofeng Energy [4]. - Investment Theme 5: Attention to vitamin products with supply disruptions, particularly due to BASF's announcement of force majeure affecting vitamin A and E supplies. Suggested companies include Zhejiang Medicine and New Hecheng [5].

Investment Rating - The investment rating for the company is "Buy" and is maintained [8]. Core Views - The company reported a strong performance in Q1 2025, achieving revenue of 1.49 billion yuan, a year-on-year increase of 43.1%, and a net profit attributable to shareholders of 200 million yuan, up 50.0% year-on-year [6][12]. - The company is a leading player in the domestic phosphate chemical industry, with significant increases in phosphate rock production capacity [12]. - The company has implemented a "mining integration" industrial model to enhance the utilization of low-grade phosphate rock and ensure stable supply of raw materials [12]. - The company plans to continue expanding its phosphate production capacity, with projected net profits of 1.33 billion yuan, 1.54 billion yuan, and 1.70 billion yuan for 2025, 2026, and 2027 respectively [12]. Summary by Sections Financial Performance - In Q1 2025, the company achieved a gross margin of 28.8% and a net margin of 14.1%, with a year-on-year change of -5.1 percentage points and +2.2 percentage points respectively [12]. - The company’s revenue and profit growth were driven by increased sales volumes and higher prices of key products, including dihydrogen phosphate and ammonium phosphate [12]. Production Capacity - The company currently has a phosphate rock production capacity of 3 million tons per year and is constructing additional capacity of 9.3 million tons per year [12]. - New projects, such as the 200,000 tons/year semi-hydrated and dihydrated wet-process phosphoric acid project, have started production, contributing to sales growth [12]. Market Outlook - The company expects continued strong demand for its core products in Q2 2025, driven by domestic spring farming needs and stable demand for iron phosphate [12]. - The company’s pricing for key products is projected to increase in Q2 2025, further enhancing profitability [12].

Investment Rating - The report assigns a "Buy" rating for Chuanheng Co., Ltd. (002895.SZ) for the first time [1][10]. Core Views - The significant increase in phosphoric acid production and sales has driven the company's high growth in performance, with a total revenue of 5.906 billion yuan in 2024, up 36.72% year-on-year, and a net profit attributable to shareholders of 956 million yuan, up 24.80% year-on-year [1][2]. Summary by Sections Revenue Growth - The company's revenue increased by 1.586 billion yuan year-on-year, primarily due to the production launch of the 200,000 tons/year semi-hydrated and dihydrate phosphoric acid and deep processing project by its subsidiary, Guangxi Pengyue. This new capacity significantly boosted product sales [2]. - Phosphoric acid production and sales grew by 96.57% and 107.89% year-on-year, contributing 1.872 billion yuan to revenue, a year-on-year increase of 120.63% [2]. - Feed-grade dicalcium phosphate production and sales increased by 23.11% and 15.81%, contributing 1.445 billion yuan to revenue, a year-on-year growth of 20.16% [2]. - Monoammonium phosphate production and sales rose by 23.57% and 15.68%, contributing 1.176 billion yuan to revenue, a year-on-year increase of 26.21% [2]. Cost and Cash Flow - The overall expense ratio decreased, with sales, management, and financial expense ratios down by 0.11%, 1.42%, and 1.36% respectively, while R&D expenses increased slightly [3]. - The net cash flow from operating activities for 2024 was 859 million yuan, an increase of 331 million yuan year-on-year, mainly due to increased sales profits and government subsidies [3]. Shareholder Returns and R&D Investment - The company maintained a stable dividend policy, distributing 12.00 yuan (including tax) per 10 shares, with a payout ratio of 67.58% and a dividend yield of 4.88% [4]. - R&D expenses increased by 37.37% year-on-year, focusing on projects such as the stability research of semi-hydrated phosphogypsum filling bodies and new crystallization processes [4]. Profit Forecast - The company is expected to gradually expand its phosphate rock production capacity, with projected net profits attributable to shareholders of 1.217 billion yuan, 1.407 billion yuan, and 1.688 billion yuan for 2025, 2026, and 2027 respectively, corresponding to PE ratios of 10.2, 8.8, and 7.3 times [10][12].

Investment Rating - The report assigns a "Buy" rating for Chuanheng Co., Ltd. (002895.SZ) for the first time [1][10]. Core Views - The significant increase in phosphoric acid production and sales has driven the company's high growth in performance, with a total revenue of 5.906 billion yuan in 2024, up 36.72% year-on-year, and a net profit attributable to shareholders of 956 million yuan, up 24.80% year-on-year [1][2]. Summary by Sections Revenue Growth - The company's revenue increased by 1.586 billion yuan year-on-year, primarily due to the production launch of the 200,000 tons/year semi-hydrated and dihydrate phosphoric acid and deep processing project by its subsidiary, Guangxi Pengyue. This new capacity significantly boosted product sales [2]. - Phosphoric acid production and sales grew by 96.57% and 107.89% year-on-year, contributing 1.872 billion yuan to revenue, a year-on-year increase of 120.63% [2]. - Feed-grade dicalcium phosphate production and sales increased by 23.11% and 15.81%, contributing 1.445 billion yuan to revenue, a year-on-year growth of 20.16% [2]. - Monoammonium phosphate production and sales rose by 23.57% and 15.68%, contributing 1.176 billion yuan to revenue, a year-on-year increase of 26.21% [2]. Cost and Cash Flow - The overall expense ratio decreased, with sales, management, and financial expense ratios down by 0.11%, 1.42%, and 1.36% respectively, while R&D expenses remained stable [3]. - The net cash flow from operating activities for 2024 was 859 million yuan, an increase of 331 million yuan year-on-year, mainly due to increased sales profits and government subsidies [3]. Shareholder Returns and R&D Investment - The company maintained a stable dividend policy, distributing 12.00 yuan (including tax) per 10 shares, with a payout ratio of 67.58% and a dividend yield of 4.88% [4]. - R&D expenses increased by 37.37% year-on-year, focusing on projects such as the stability research of semi-hydrated phosphogypsum filling bodies and new crystallization processes [4]. Profit Forecast - The company is expected to gradually expand its phosphate rock production capacity, with projected net profits attributable to shareholders of 1.217 billion yuan, 1.407 billion yuan, and 1.688 billion yuan for 2025-2027, corresponding to PE ratios of 10.2, 8.8, and 7.3 times respectively [10][12].

Investment Rating - The report assigns an "Accumulate" rating to the company, indicating a potential upside of over 15% relative to the CSI 300 index [19]. Core Views - The company achieved a 23.01% year-on-year growth in net profit after deducting non-recurring items for 2024, primarily driven by the release of new project capacities and increased product sales [2][12]. - The company plans to distribute a minimum cash dividend of 646 million yuan for 2024, with a proposed dividend of 12 yuan per 10 shares [12]. - The company has launched a stock incentive plan for 2025, proposing to grant 9.309 million restricted shares at a price of 11.40 yuan per share [12]. Financial Summary - The company reported revenues of 5,906 million yuan in 2024, a 36.72% increase year-on-year, with a net profit of 956 million yuan, reflecting a 24.80% growth [12]. - The projected revenues for 2025, 2026, and 2027 are 7,088 million yuan, 7,713 million yuan, and 8,450 million yuan, respectively, with corresponding net profits of 1,284 million yuan, 1,537 million yuan, and 1,763 million yuan [4][12]. - The earnings per share (EPS) are expected to be 2.38 yuan for 2025, 2.85 yuan for 2026, and 3.27 yuan for 2027 [12]. Market Data - The company's stock price has ranged between 15.92 yuan and 24.90 yuan over the past 52 weeks, with a total market capitalization of 12,287 million yuan [7]. - The company has a net asset value per share of 11.46 yuan, with a price-to-book ratio of 2.0 [8]. Dividend and Share Buyback - The company has initiated a share buyback program, repurchasing 3,318,406 shares, which were successfully canceled [12]. - The board has proposed a mid-term dividend plan, contingent on meeting specific profitability and cash flow criteria [12].

Group 1 - The company reported a revenue of 1.493 billion yuan for the first quarter of 2025, representing a year-on-year increase of 43.07% [1] - The net profit for the same period was 202 million yuan, showing a year-on-year growth of 50.02% [1]

Investment Rating - The investment rating for the company is "Buy" (maintained) [2] Core Views - The company reported a significant increase in both revenue and profit for the year 2024, driven by capacity release and rising product prices. The total revenue reached 5.906 billion yuan, a year-on-year increase of 36.72%, while the net profit attributable to shareholders was 956 million yuan, up 24.80% year-on-year [5][6] - The company's main products, including feed-grade dicalcium phosphate, monoammonium phosphate, phosphoric acid, and phosphate rock, contributed to the revenue growth, with notable increases in sales and prices [6][7] - The company is expanding its international trade capabilities by increasing capital in its subsidiaries, which is expected to enhance its growth potential [8][9] - The high market price of phosphate rock is expected to support the company's profitability in the long term, with plans to increase phosphate rock production capacity [10] - Profit forecasts for the company indicate a continued upward trend in net profit for the years 2025 to 2027, with expected figures of 1.229 billion, 1.447 billion, and 1.856 billion yuan respectively [11] Summary by Sections Financial Performance - In 2024, the company achieved a revenue of 5.906 billion yuan and a net profit of 956 million yuan, with respective year-on-year growth rates of 36.72% and 24.80% [5][6] - The fourth quarter of 2024 saw a revenue of 1.932 billion yuan, a year-on-year increase of 54.83% [5] Product Pricing and Market Conditions - The average market prices for key products in 2024 were as follows: wet phosphoric acid at 6,082.07 yuan/ton, industrial-grade monoammonium phosphate at 5,672.92 yuan/ton, and feed-grade dicalcium phosphate at 3,754.76 yuan/ton, with year-on-year changes of -7.32%, +1.67%, and +7.20% respectively [7] - The company anticipates continued price increases for its main products in 2025 due to strong demand [6][7] Strategic Developments - The company has established a new subsidiary and increased capital in its Hong Kong subsidiary to enhance international trade operations [8][9] - Plans to expand phosphate rock production capacity are underway, which will support long-term growth [10] Profit Forecasts - Expected net profits for 2025, 2026, and 2027 are projected to be 1.229 billion, 1.447 billion, and 1.856 billion yuan, respectively, with corresponding P/E ratios of 10, 8, and 7 [11]

Summary of Key Points from Conference Call Industry Overview - The conference call primarily discusses the impact of the ongoing trade war on various sectors, particularly focusing on the Chinese capital market and its resilience amid global financial uncertainties [2][3][4]. Core Insights and Arguments 1. **Chinese Government Measures**: The Chinese government has implemented several measures to stabilize the capital market, including the release of new funds by the central bank and coordination by the State-owned Assets Supervision and Administration Commission (SASAC) to support stock prices [3][6]. 2. **Impact of Tariffs**: The U.S. has granted tariff exemptions on certain Chinese products like mobile phones and semiconductors, which is seen as a preliminary victory in trade competition. If U.S. Treasury yields continue to decline, further exemptions may be added, providing upward potential for Chinese assets [3][4]. 3. **Economic Pressure**: The Chinese economy is expected to face pressure in the next two quarters due to tariffs affecting earnings per share (EPS). Although there are expectations for domestic demand stimulus policies, they are unlikely to fully offset negative impacts [5][6]. 4. **High Dividend Strategy**: In the current environment, high dividend strategies are favored as companies in this category are less exposed to foreign debt risks. The AI sector in China is highlighted as having long-term potential [6][7]. 5. **Utilities Sector Performance**: The utilities sector, particularly hydropower, has shown strong performance with significant year-on-year growth in electricity generation. Companies like Huaneng Hydropower and Yangtze Power have reported substantial increases in output [7][8]. 6. **Gold Market Trends**: The escalation of trade tensions has led to rising gold prices, with gold stocks showing excess returns. The changing global political landscape is a key driver, with expectations of a long-term bull market for gold [10][11]. 7. **Petrochemical Sector Performance**: The petrochemical index has underperformed during the trade war, but sub-sectors like refining and oil services have shown strong excess returns. The decline in oil prices has improved cost structures, leading to a recovery in refining profits [15][16]. Additional Important Insights 1. **Electricity Sector Impact**: Tariffs have a significant impact on the thermal power sector, while hydropower remains stable. Hydropower companies are expected to maintain high dividend payouts, making them attractive for long-term investment [8][9]. 2. **Oil Price Trends**: Recent oil price fluctuations have been influenced by the trade war, with prices dropping from $75 to around $65. The outlook remains cautious, with expectations of prices stabilizing between $60 and $70 [13][14]. 3. **Investment Opportunities in Chemicals**: The agricultural chemicals market is expected to perform well, with specific companies recommended for investment based on their growth potential in the fertilizer sector [22][23]. 4. **Steel Industry Outlook**: The steel sector is seen as a potential investment opportunity due to expected policy changes aimed at improving industry concentration and profitability in the second half of the year [34]. This summary encapsulates the key points discussed in the conference call, highlighting the resilience of the Chinese market amid trade tensions and identifying potential investment opportunities across various sectors.

Group 1 - The report highlights steady revenue growth for Chuanheng Co., with a 2024 revenue of 5.906 billion yuan, a year-on-year increase of 36.72% [3][5] - The net profit attributable to shareholders for 2024 reached 956 million yuan, up 24.80% year-on-year, with a weighted average return on equity (ROE) of 16.19% [3][5] - The company’s Q4 2024 revenue was 1.932 billion yuan, showing a year-on-year increase of 54.83% and a quarter-on-quarter increase of 29.73% [4][6] Group 2 - The report indicates that the price of phosphate rock remains high, with an average price of 1,018 yuan/ton in Q1 2025, reflecting a year-on-year increase of 1% [8] - The company has acquired a 58.5% stake in Qianyuan Geological Exploration, enhancing its phosphate resource advantages [9] - The company plans to distribute a cash dividend of 12.00 yuan per 10 shares, amounting to approximately 646 million yuan, which is 67.58% of the annual net profit [10] Group 3 - The report discusses the performance of Industrial and Commercial Bank of China (ICBC), noting a 2024 revenue of 821.803 billion yuan, a year-on-year decrease of 2.52% [25][26] - ICBC's net profit for 2024 was 365.863 billion yuan, with a quarterly growth rate of 1.59% in Q4 [26][28] - The bank's non-performing loan ratio improved to 1.34%, down from the previous quarter, indicating enhanced asset quality [27][28] Group 4 - The report on Shanghai Pudong Development Bank (SPDB) indicates a 2024 revenue decline of 1.55%, but a net profit increase of 23.31%, marking the highest growth rate in five years [30][31] - The bank's non-performing loan ratio decreased to 1.36%, reflecting improved asset quality [32] - SPDB's total assets grew by 5.05% year-on-year, with a loan total increase of 7.45% [31][32] Group 5 - The report on the computer industry emphasizes the impact of "reciprocal tariffs" on global industrial patterns, accelerating China's self-reliance and independent control processes [34][37] - The domestic software and hardware markets are expected to benefit from the tariff policies, with significant growth opportunities identified [34][36] - The report suggests that the domestic chip industry will see accelerated localization, with increased resilience and growth potential [36][37] Group 6 - The report on Nanji E-commerce highlights the company's transformation into a brand authorization model, with a focus on quality and rapid response [41] - The company aims to capitalize on the "alternative to big brands" trend, with a projected revenue growth of 20% to 61.88 billion yuan from 2024 to 2026 [42][43] - The light luxury brand launched by the company has shown promising sales performance, indicating strong market potential [42][43] Group 7 - The report on Focus Media discusses the acquisition of New潮传媒, which is expected to enhance the company's market position and revenue potential [44][45] - The acquisition is projected to optimize the competitive landscape of the outdoor advertising industry, potentially increasing the company's market share [46] - Historical acquisitions by Focus Media have led to significant revenue growth, suggesting a positive outlook for this acquisition [47]